X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3291) 3291
Book Review (696) 696
Newsletter (369) 369
Newspaper Article (147) 147
Publication (123) 123
Magazine Article (51) 51
Conference Proceeding (20) 20
Trade Publication Article (15) 15
Book Chapter (8) 8
Data Set (3) 3
Dissertation (2) 2
Paper (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
multiple sclerosis (2385) 2385
index medicus (2271) 2271
humans (2264) 2264
interferon beta-1b (1476) 1476
clinical neurology (1288) 1288
female (1107) 1107
adult (1047) 1047
interferon (1042) 1042
interferon-beta - therapeutic use (1036) 1036
male (1029) 1029
multiple sclerosis - drug therapy (887) 887
interferon beta-1a (874) 874
interferon beta (738) 738
middle aged (727) 727
double-blind (710) 710
neurosciences (710) 710
biological response modifiers (548) 548
glatiramer acetate (533) 533
multiple sclerosis, relapsing-remitting - drug therapy (504) 504
neurology (494) 494
treatment outcome (493) 493
placebo-controlled trial (481) 481
research (479) 479
care and treatment (457) 457
magnetic resonance imaging (457) 457
adjuvants, immunologic - therapeutic use (452) 452
drug therapy (409) 409
disease progression (391) 391
interferon-beta (388) 388
multicenter (365) 365
therapy (358) 358
disability (343) 343
interferon-beta - administration & dosage (317) 317
abridged index medicus (316) 316
interferon-beta - adverse effects (310) 310
multiple sclerosis - immunology (299) 299
immunology (282) 282
medicine & public health (269) 269
multiple sclerosis - therapy (268) 268
immunologic factors - therapeutic use (255) 255
pharmacology & pharmacy (249) 249
disability evaluation (240) 240
immunosuppressive agents - therapeutic use (238) 238
multiple-sclerosis (237) 237
adolescent (231) 231
clinical trials (229) 229
disease (224) 224
medical research (224) 224
neutralizing antibodies (223) 223
time factors (221) 221
recurrence (216) 216
peptides - therapeutic use (214) 214
health aspects (211) 211
patients (211) 211
multiple sclerosis - diagnosis (208) 208
animals (202) 202
follow-up studies (200) 200
psychiatry (200) 200
interferon-beta - immunology (197) 197
mri (197) 197
medicine, experimental (186) 186
medicine, general & internal (185) 185
multiple sclerosis - pathology (184) 184
brain - pathology (183) 183
young adult (183) 183
risk factors (179) 179
adjuvants, immunologic - administration & dosage (177) 177
multiple sclerosis - physiopathology (177) 177
analysis (174) 174
interferon-beta - pharmacology (171) 171
clinical trials as topic (164) 164
dosage and administration (163) 163
aged (160) 160
diagnostic-criteria (159) 159
natalizumab (157) 157
pharmaceutical industry (157) 157
adjuvants, immunologic - adverse effects (153) 153
follow-up (153) 153
experimental autoimmune encephalomyelitis (152) 152
retrospective studies (152) 152
development and progression (150) 150
studies (150) 150
medicine (149) 149
drugs (146) 146
prospective studies (144) 144
cytokines (142) 142
trial (139) 139
natural-history (137) 137
central-nervous-system (135) 135
neuroradiology (135) 135
recombinant proteins - therapeutic use (133) 133
antibodies (131) 131
reports (130) 130
ifn-beta (129) 129
research article (129) 129
secondary progressive ms (129) 129
multiple sclerosis, relapsing-remitting - immunology (127) 127
remitting multiple-sclerosis (127) 127
usage (126) 126
dose-response relationship, drug (125) 125
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3600) 3600
German (103) 103
Spanish (46) 46
Russian (42) 42
French (33) 33
Japanese (13) 13
Polish (11) 11
Czech (7) 7
Hungarian (5) 5
Portuguese (5) 5
Croatian (3) 3
Dutch (3) 3
Turkish (3) 3
Italian (2) 2
Korean (2) 2
Chinese (1) 1
Danish (1) 1
Persian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurology, ISSN 0028-3878, 11/2004, Volume 63, Issue 10, pp. 1788 - 1795
Journal Article
Journal of the Neurological Sciences, ISSN 0022-510X, 2011, Volume 307, Issue 1, pp. 120 - 126
Abstract Background Low adherence to treatment in Multiple Sclerosis (MS) has been shown to lead to poor health outcomes. Various strategies to improve... 
Neurology | Multiple Sclerosis | Adherence | Interferon beta-1b | Coping styles | Nurses | Autoinjector devices | MEDICATION | DEPRESSION SCALE | ANXIETY | RELIABILITY | NEUROSCIENCES | CLINICAL NEUROLOGY | THERAPY | PEOPLE | INTERFERONS | VALIDITY | SPECIALIST | Multiple sclerosis | Biological response modifiers | Analysis | Interferon beta
Journal Article
Journal Article
NEUROLOGY, ISSN 0028-3878, 04/2012, Volume 78, Issue 17, pp. 1315 - 1322
Objective: To examine the effects of interferon beta (IFN beta)-1b on all-cause mortality over 21 years in the cohort of 372 patients who participated in the... 
REMITTING MULTIPLE-SCLEROSIS | OXIDATIVE STRESS | MULTICENTER | DANISH PATIENTS | DOUBLE-BLIND | MITOCHONDRIAL DYSFUNCTION | DEATH | PLACEBO-CONTROLLED TRIAL | CLINICAL NEUROLOGY | INTERFERON BETA-1A THERAPY
Journal Article
Journal Article
Neurology, ISSN 0028-3878, 11/2004, Volume 63, Issue 10, pp. 1779 - 1787
Journal Article